| Advances on presepsin in the diagnosis and prognosis of sepsis |
| Received:January 24, 2019 Revised:March 09, 2019 Click here to download the full text |
| Citation of this paper:周燕南，慕婉晴，顾国嵘，姚晨玲.Advances on presepsin in the diagnosis and prognosis of sepsis[J].Chinese Journal of Clinical Medicine,2019,26(4):647-652 |
| Hits: 1734 |
| Download times: 782 |
|
| Abstract:Sepsis is one of the diseases with high mortality in acute and critical diseases，and its early diagnosis and intervention can improve the occurrence of adverse endpoint events and reduce the mortality to a certain extent. The classical biomarkers of sepsis, procalcitonin (PCT) and Creactive protein (CRP) have certain limitations in early identification and prognosis risk assessment of sepsis. Presepsin sCD14ST, as a newly discovered biomarker for sepsis diagnosis, has a good application prospect in the early diagnosis, treatment, and prognosis of sepsis. |
| keywords:sepsis presepsin sCD14ST diagnosis prognosis |
| HTML View Full Text View/Add Comment Download reader |